STAAR Surgical Gross Profit 2010-2025 | STAA

STAAR Surgical gross profit from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
STAAR Surgical Annual Gross Profit
(Millions of US $)
2024 $240
2023 $253
2022 $223
2021 $179
2020 $118
2019 $112
2018 $92
2017 $64
2016 $58
2015 $53
2014 $49
2013 $50
2012 $44
2011 $42
2010 $35
2009 $31
STAAR Surgical Quarterly Gross Profit
(Millions of US $)
2025-03-31 $28
2024-12-31 $32
2024-09-30 $68
2024-06-30 $78
2024-03-31 $61
2023-12-31 $61
2023-09-30 $64
2023-06-30 $71
2023-03-31 $58
2022-12-31 $50
2022-09-30 $60
2022-06-30 $64
2022-03-31 $49
2021-12-31 $45
2021-09-30 $45
2021-06-30 $49
2021-03-31 $39
2020-12-31 $34
2020-09-30 $35
2020-06-30 $24
2020-03-31 $25
2019-12-31 $29
2019-09-30 $29
2019-06-30 $30
2019-03-31 $24
2018-12-31 $23
2018-09-30 $24
2018-06-30 $25
2018-03-31 $19
2017-12-31 $17
2017-09-30 $17
2017-06-30 $15
2017-03-31 $15
2016-12-31 $16
2016-09-30 $15
2016-06-30 $15
2016-03-31 $13
2015-12-31 $15
2015-09-30 $13
2015-06-30 $12
2015-03-31 $13
2014-12-31 $9
2014-09-30 $12
2014-06-30 $14
2014-03-31 $14
2013-12-31 $13
2013-09-30 $12
2013-06-30 $13
2013-03-31 $13
2012-12-31 $11
2012-09-30 $11
2012-06-30 $11
2012-03-31 $11
2011-12-31 $11
2011-09-30 $10
2011-06-30 $11
2011-03-31 $10
2010-12-31 $9
2010-09-30 $8
2010-06-30 $9
2010-03-31 $9
2009-12-31 $8
2009-09-30 $8
2009-06-30 $8
2009-03-31 $8
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.882B $0.314B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.020B 21.74
Becton Dickinson (BDX) United States $49.466B 12.25
Cardinal Health (CAH) United States $36.861B 19.31
Labcorp (LH) United States $20.839B 16.90
Straumann Holding AG (SAUHY) Switzerland $20.586B 0.00
West Pharmaceutical Services (WST) United States $15.149B 31.75
Cooper (COO) United States $13.655B 17.60
Align Technology (ALGN) United States $13.115B 26.03
Henry Schein (HSIC) United States $8.519B 14.61
Merit Medical Systems (MMSI) United States $5.616B 27.15
DENTSPLY SIRONA (XRAY) United States $3.185B 9.51
CONMED (CNMD) United States $1.756B 13.14
Lifevantage (LFVN) United States $0.164B 16.95
Pro-Dex (PDEX) United States $0.131B 14.30